Mirko Rivara

4PUBLICATIONS
17CO-AUTHORS
Molecular targetsGlycoconjugatesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2026
Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment.

|Apr 28, 2023
Chemico-Physical Properties of Some 1,1'-Bis-alkyl-2,2'-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery.

Michele Massa, Mirko Rivara, Thelma A Pertinhez

|Mar 25, 2022
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers.

Michele Massa, Mirko Rivara, Gaetano Donofrio

|Jan 21, 2022
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines.

Alessio Malacrida, Alessandro Di Domizio, Angela Bentivegna

Pageof 1

Frequent Collaborators

2 joint publications

Angela Bentivegna

2 joint publications

Valentina Zuliani

2 joint publications

Gabriella Nicolini

2 joint publications

Luigi Cristofolini